Trial intelligence / Profile preview

Dexmedetomidine premedication in pediatric tonsillectomy anesthesia

IRCT20130812014333N108Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-blind trial of dexmedetomidine (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Bleeding, Nausea and 2 more. Started Dec 2018; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on IRCT20130812014333N108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130812014333N108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call